ALISHA STINEMETZ: Open Payments
NPI 1083144539 · LYONS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 25 payments from 13 companies in 2025. Trend: 2023 $216 · 2024 $280 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Alkermes, Inc. | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $35 |
| Lundbeck LLC | 2 | $33 |
| Amgen Inc. | 2 | $33 |
| PFIZER INC. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $17 |
Products named: LEQVIO, REXULTI, ARISTADA, INVEGA SUSTENNA, VRAYLAR, EVENITY, UZEDY, LYBALVI.
Industry payments across KS — which companies pay providers there.
